|
| Session | Topic | Speaker | Institution |
|
| Clinical Sciences | HCV Treatment in the Era of Highly Effective Antiviral Therapy | Mark Sulkowski | Johns Hopkins University (Baltimore, USA) |
| HCV Care Clarity and Chaos in Canada | Curtis Cooper | University of Ottawa (Ottawa, Canada) |
| Efficacy of Sofosbuvir Treatment Regimens in Real Life Settings | Emmanuelle Huchet | Clinique l’Actuel (Montréal, Canada) |
|
| Biomedical Sciences | Viral and Host Factors of Hepatitis C Virus RNA Replication | Volker Lohmann | University of Heidelberg (Heidelberg, Germany) |
| Resistance to HCV NS5A and NS5B Inhibitors | Matthias Götte | University of Alberta (Edmonton, Canada) |
|
| Behavioural Sciences | Contradictions between Law Enforcement and Public Health: The Hepatitis C Risk Environment | Philippe Bourgois | University of Pennsylvania (Philadelphia, USA) |
| LiveRLife: A Liver Health Promotion Campaign | Jason Grebely | University of New South Wales (Sydney, Australia) |
|
| Epidemiology and Public Health | Scotland’s Action Plan on Hepatitis C | Sharon Hutchinson | Glasgow Caledonian University (Glasgow, Scotland) |
| Burden of HCV in Canada and Management Strategies | Rob Myers | University of Calgary (Calgary, Canada) |
|
| A Plan for Canada | Beyond the Medication: Resources Needed for Successful Treatment | Magdalena Kuczynski | Toronto Western Hospital (Toronto, Canada) |
| HCV Patient Advocacy in Canada | Daryl Luster | Action Hepatitis Canada (Vancouver, Canada) |
| Status of the National HCV Task Group | Mel Krajden | University of British Columbia (Vancouver, Canada) |
| CIHR Funding for HCV Research in Canada | Marc Ouellette | Canadian Institutes of Health Research (CIHR) (Québec, Canada) |
|
